A center focused on advancing leukemia treatment through collaborative research.
ECOG-ACRIN Integrated Leukemia Translational Science Center (LTSC)
The Leukemia Translational Science Center is working with a team of experts to find new and better treatments for leukemia, using the latest technology and research to help improve care for patients like you.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Sloan-Kettering Inst Can Research NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-11250227 on NIH RePORTER |
What this research studies
The Leukemia Translational Science Center (LTSC) is designed to lead and coordinate innovative studies in leukemia, bringing together experts from various fields such as clinical investigation, laboratory science, and computational biology. By utilizing advanced genomic technologies and a comprehensive data warehouse, the LTSC aims to accelerate the development of high-quality clinical trials. This collaborative effort will involve both junior and senior researchers, fostering teamwork to explore new treatment avenues and improve patient outcomes. The center will also provide funding for pilot projects to support groundbreaking research initiatives.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals diagnosed with leukemia who are seeking innovative treatment options.
Not a fit: Patients with conditions other than leukemia may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective treatments and improved outcomes for patients with leukemia.
How similar studies have performed: Previous research initiatives in leukemia have shown promise in utilizing collaborative and translational approaches, indicating a strong potential for success in this novel center.
Where this research is happening
New York, United States
- Sloan-Kettering Inst Can Research — New York, United States (Active)
Researchers
- Principal investigator: Levine, Ross L — Sloan-Kettering Inst Can Research
- Study coordinator: Levine, Ross L
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.